Systemic lupus erythematosus (SLE) induced by biologics mostly occurs during the treatment of psoriasis with tumor necrosis factor-alpha (TNF-α) inhibitors, especially in patients with psoriatic and rheumatoid arthritis. The gene discussed is TNF; the disease is rheumatoid arthritis.